259 related articles for article (PubMed ID: 17159461)
1. Anti-androgenic treatment of obsessive-compulsive disorder: an open-label clinical trial of the long-acting gonadotropin-releasing hormone analogue triptorelin.
Eriksson T
Int Clin Psychopharmacol; 2007 Jan; 22(1):57-61. PubMed ID: 17159461
[TBL] [Abstract][Full Text] [Related]
2. Long-term fluoxetine treatment of a large number of obsessive-compulsive patients.
Levine R; Hoffman JS; Knepple ED; Kenin M
J Clin Psychopharmacol; 1989 Aug; 9(4):281-3. PubMed ID: 2504781
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
Liebowitz MR; Hollander E; Schneier F; Campeas R; Hatterer J; Papp L; Fairbanks J; Sandberg D; Davies S; Stein M
J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337
[TBL] [Abstract][Full Text] [Related]
4. Electroacupuncture for refractory obsessive-compulsive disorder: a pilot waitlist-controlled trial.
Zhang ZJ; Wang XY; Tan QR; Jin GX; Yao SM
J Nerv Ment Dis; 2009 Aug; 197(8):619-22. PubMed ID: 19684500
[TBL] [Abstract][Full Text] [Related]
5. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
6. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone.
Rösler A; Witztum E
N Engl J Med; 1998 Feb; 338(7):416-22. PubMed ID: 9459644
[TBL] [Abstract][Full Text] [Related]
7. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
Ma N; Tan LW; Wang Q; Li ZX; Li LJ
Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595
[TBL] [Abstract][Full Text] [Related]
8. [Ziprasidone as coadjuvant treatment in resistant obsessive-compulsive disorder treatment].
Iglesias Garcia C; Santamarina Montila S; Alonso Villa MJ
Actas Esp Psiquiatr; 2006; 34(4):277-9. PubMed ID: 16823689
[TBL] [Abstract][Full Text] [Related]
9. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
Rabinowitz I; Baruch Y; Barak Y
Int Clin Psychopharmacol; 2008 Jan; 23(1):49-53. PubMed ID: 18090508
[TBL] [Abstract][Full Text] [Related]
10. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
[TBL] [Abstract][Full Text] [Related]
11. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].
Salmerón JM; Alcántara AG; Barcia D
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):399-402. PubMed ID: 9972593
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
Poyurovsky M; Faragian S; Shabeta A; Kosov A
Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of hypersexuality in a male with obsessive compulsive disorder as psychiatric co-morbidity].
Jairam J; van Marle HJ
Tijdschr Psychiatr; 2008; 50(2):113-7. PubMed ID: 18264903
[TBL] [Abstract][Full Text] [Related]
14. Cerebral activation in children and adolescents with obsessive-compulsive disorder before and after treatment: a functional MRI study.
Lázaro L; Caldú X; Junqué C; Bargalló N; Andrés S; Morer A; Castro-Fornieles J
J Psychiatr Res; 2008 Oct; 42(13):1051-9. PubMed ID: 18261744
[TBL] [Abstract][Full Text] [Related]
15. Considerable improvement in a case of obsessive-compulsive disorder in an emotionally unstable personality disorder, borderline type under treatment with clozapine.
Steinert T; Schmidt-Michel PO; Kaschka WP
Pharmacopsychiatry; 1996 May; 29(3):111-4. PubMed ID: 8738316
[TBL] [Abstract][Full Text] [Related]
16. [Schizophrenia and obsessive-compulsive disorder--some considerations based on a case].
Sümeg S; Herold R; Tényi T
Psychiatr Hung; 2005; 20(1):35-9. PubMed ID: 16389732
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
[No Abstract] [Full Text] [Related]
18. Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder.
McDougle CJ; Barr LC; Goodman WK; Pelton GH; Aronson SC; Anand A; Price LH
Am J Psychiatry; 1995 Dec; 152(12):1812-4. PubMed ID: 8526253
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of schizophrenia co-morbid with obsessive-compulsive disorder.
Sayeed Khan MN; Arshad N; Ullah N
J Coll Physicians Surg Pak; 2004 Apr; 14(4):234-6. PubMed ID: 15228829
[TBL] [Abstract][Full Text] [Related]
20. [Is it time for revision of the section on obsessive-compulsive disorder in the Guideline on Anxiety Disorders?].
van Ingen Schenau WJ; Wisman PW
Tijdschr Psychiatr; 2007; 49(5):315-25. PubMed ID: 17492582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
